Bioventus Inc (BVS)
11.64
+0.59
(+5.34%)
USD |
NASDAQ |
Sep 27, 16:00
11.65
+0.01
(+0.09%)
After-Hours: 20:00
Bioventus Accounts Receivable (Quarterly): 137.30M for June 30, 2024
Accounts Receivable (Quarterly) Chart
Historical Accounts Receivable (Quarterly) Data
Date | Value |
---|---|
June 30, 2024 | 137.30M |
March 31, 2024 | 125.54M |
December 31, 2023 | 122.79M |
September 30, 2023 | 112.90M |
June 30, 2023 | 119.64M |
March 31, 2023 | 118.54M |
December 31, 2022 | 136.30M |
September 30, 2022 | 132.18M |
June 30, 2022 | 143.02M |
Date | Value |
---|---|
March 31, 2022 | 119.29M |
December 31, 2021 | 124.96M |
September 30, 2021 | 105.44M |
June 30, 2021 | 102.03M |
March 31, 2021 | 89.47M |
December 31, 2020 | 88.28M |
September 30, 2020 | 80.81M |
December 31, 2019 | 85.13M |
March 31, 2016 | 51.11M |
Accounts Receivable Definition
Account used to record sales made "on account", meaning that the company has made a sale but has not collected payment. When company collects cash as payment, the corresponding account receivable is decreased.
Accounts Receivable (Quarterly) Range, Past 5 Years
80.81M
Minimum
Sep 2020
143.02M
Maximum
Jun 2022
114.33M
Average
119.29M
Median
Mar 2022
Accounts Receivable (Quarterly) Benchmarks
Perspective Therapeutics Inc | 0.142M |
Retractable Technologies Inc | 4.690M |
InfuSystems Holdings Inc | 21.32M |
Xtant Medical Holdings Inc | 21.19M |
Catheter Precision Inc | 0.105M |